Congressional marijuana provisions; DEA psychedelic quotas; FL AG: Keep legalization off ballot; Industry group’s Trump PAC ...
The Drug Enforcement Administration (DEA) says the marijuana rescheduling appeal process “remains pending” despite President ...
President Trump's executive order to reclassify marijuana into a Schedule III drug is only the beginning. The big picture: Reclassification is a lengthy process that would change how marijuana can be ...
How Oklahoma's marijuana businesses are likely to be impacted by Donald Trump's executive order calling on the DOJ to ...
This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally exposed the truth: the DEA marijuana obstruction was never about public safety. It ...
How Presidential Leadership Exposed a Marijuana Bureaucracy That Failed Patients, Science, and the Constitution.The only question left is whether the DEA will finally follow the President's lead - or ...
"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within the timelines required by law, resulting in years-long delay of medical cannabis ...
While users may think that rescheduling marijuana to Schedule III will legalize the drug, Trump is focusing on the research ...
WASHINGTON, D.C. / ACCESS Newswire / December 20, 2025 / President Donald J. Trump's recent Executive Order on marijuana research and rescheduling has fundamentally changed the federal cannabis ...
WASHINGTON, D.C. / ACCESS Newswire / December 3, 2025 / MMJ International Holdings, a pharmaceutical developer of a fully federally compliant, natural cannabinoid pharmaceutical for Huntington's ...
The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have access to controlled substances for legitimate medical use. Today, the evidence shows the opposite: ...
How Presidential Leadership Exposed a Marijuana Bureaucracy That Failed Patients, Science, and the Constitution.The only ...